Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
5(100.0%)
5Total
Phase 1(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05485012Phase 1Completed

Reinforcing Effects of Marijuana and Opioids

Role: lead

NCT06601218Phase 1Recruiting

Impact of Daily Oral Cannabis Doses in Patients With Cancer

Role: lead

NCT06757140Phase 1Recruiting

Opioid Drug Interaction Study

Role: lead

NCT03705559Phase 1Completed

Opioid and Cannabinoid Interactions

Role: lead

NCT03699540Phase 1Completed

Marijuana Effects on Simulated Driving Performance

Role: lead

All 5 trials loaded